Xenon Pharmaceuticals adopts 2026 Equity Incentive Plan effective June 2, 2026
Xenon Pharmaceuticals Inc. established a new equity incentive plan to grant options, restricted shares, RSUs and other share-based awards to employees, officers, directors and consultants. The plan is designed to attract and retain talent while aligning employee interests with sh
View filing at SEC.gov →